We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAew Uk Reit Regulatory News (AEWU)

Share Price Information for Aew Uk Reit (AEWU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.20
Bid: 83.20
Ask: 83.90
Change: 0.00 (0.00%)
Spread: 0.70 (0.841%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 83.20
AEWU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing under Placing Programme

26 Feb 2020 07:00

AEW UK REIT plc (AEWU) Result of Placing under Placing Programme 26-Feb-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), AUSTRALIA, CANADA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

 

26 February 2020

 

AEW UK REIT Plc (the "Company")

 

Result of Placing under Placing Programme

 

Further to the announcement made by the Company on 19 February 2020, the Company today announces that it has successfully raised gross proceeds of £7 million pursuant to the Placing under its Placing Programme which expires on 28 February 2020.

Accordingly, an aggregate of 7,216,495  new Ordinary Shares have been issued and allotted conditionally upon admission at a price of 97 pence per Ordinary Share.

 

Applications have been made for the admission of 7,216,495 new Ordinary Shares to listing on the premium listing segment of the Official List and to trading on the Main Market of London Stock Exchange Group plc ("Admission"). It is expected that Admission will become effective and that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 28 February 2020.

 

Following Admission, the Company will have 158,774,746 Ordinary Shares in issue. Therefore, the total number of voting rights of the Company will be 158,774,746 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

 

AEW UK

 

Alex Short

alex.short@eu.aew.com

 

+44(0) 20 7016 4848

Laura Elkin

Laura.elkin@eu.aew.com

+44(0) 20 7016 4869

Nicki Gladstone

nicki.gladstone-ext@eu.aew.com

 

+44(0) 7711 401 021

Company Secretary

 

Link Company Matters Limited

aewu.cosec@linkgroup.co.uk

 

+44(0) 1392 477 500

 

 

TB Cardew

AEW@tbcardew.com

Ed Orlebar

+44 (0) 7738 724 630

Lucas Bramwell

+44 (0) 7939 694 437

 

 

Liberum Capital

 

Gillian Martin / Owen Matthews

+44 (0) 20 3100 2000

 

 

 

LEI: 21380073LDXHV2LP5K50

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

A copy of the Prospectus is available for inspection at: www.morningstar.co.uk/uk/nsm as well as on the Company's website: https://www.aewukreit.com/.

 

Terms used but not defined in this announcement shall have the meanings given to such terms in the Prospectus dated 1 March 2019.

 

Important Notice

 

This announcement has been issued by and is the sole responsibility of the Company. Liberum Capital Limited ("Liberum"), is authorised and regulated by the Financial Conduct Authority in the United Kingdom, and is acting only for the Company in connection with the matters described in this announcement and are not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of each of them or advice to any other person in relation to the matters contained herein. Liberum, nor any of its or their respective affiliates, directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.

Neither this announcement nor the information contained herein is for publication, distribution or release, in whole or in part, directly or indirectly, in or into or from the United States (including its territories and possessions), any member state of the European Economic Area (other than the United Kingdom), Australia, Canada, South Africa, Japan or to any person in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The offer of Ordinary Shares pursuant to the Placing (the "Offer") and the distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this announcement or any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, the securities referred to herein to any person in any jurisdiction, including the United States, Australia, Canada, South Africa or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

The securities to which this announcement relates have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any regulating authority or under any applicable securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, pledged or otherwise transferred within the United States or to US persons unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable state law. There will be no public offer of the securities in the United States. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, South Africa or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada, South Africa or Japan or to any national, resident or citizen of Australia, Canada, South Africa or Japan.

 

 


ISIN:GB00BWD24154
Category Code:MSCM
TIDM:AEWU
LEI Code:21380073LDXHV2LP5K50
OAM Categories: 2.2. Inside information
3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:48891
EQS News ID:983633
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Jan 20247:00 amRNSInvestor Presentation
25th Jan 20247:00 amRNSNAV Update and Dividend Declaration
22nd Nov 20237:00 amRNSHalf Yearly Results
23rd Oct 20239:00 amRNSClosed Period – Compliance with MAR
19th Oct 202310:26 amRNSInvestor Presentation
19th Oct 20237:00 amRNSNAV Update and Dividend Declaration
9th Oct 20237:00 amRNSSale of high-street retail asset in Portsmouth
27th Sep 20237:00 amRNSNon-material changes to Investment Policy
19th Sep 20237:00 amRNSBoard Changes
14th Sep 20234:30 pmRNSResult of AGM
8th Sep 20237:00 amRNSAcquisition of high yielding mixed-use office
1st Sep 202310:41 amRNSNotice of AGM - correction
20th Jul 20237:00 amRNSNAV Update and Dividend Declaration
19th Jul 20237:00 amRNSInvestor Presentation
19th Jul 20237:00 amRNSAcquisition of high yielding mixed use asset, York
26th Jun 20237:00 amRNSSale of two industrial assets for £16.1m
21st Jun 20237:00 amRNSAnnual Financial Report
19th Jun 20236:29 pmRNSHolding(s) in Company
9th May 20237:00 amRNSDisposal of Industrial Holding in Deeside
28th Apr 20237:00 amRNSInvestor Presentation
26th Apr 20238:10 amRNSNAV Update and Dividend Declaration
20th Apr 202312:40 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSAcquisition of high-yielding retail warehouse unit
20th Mar 20237:00 amRNSSale of Unit 1, Clarke Road, Milton Keynes
28th Feb 20233:13 pmRNSNAV Update and Dividend Declaration - Replacement
23rd Jan 20237:00 amRNSInvestor Presentation
19th Jan 20237:00 amRNSNAV Update and Dividend Declaration
1st Dec 20227:00 amRNSAcquisition of two high yielding retail assets
29th Nov 20224:25 pmRNSHolding(s) in Company
24th Nov 20225:19 pmRNSDirector Declaration
16th Nov 20227:00 amRNSHalf Yearly Results
15th Nov 20227:00 amRNSNotice of Half Year Results
10th Nov 20227:00 amRNSAppointment of Non-Executive Director
24th Oct 20224:42 pmRNSClosed Period - Compliance with MAR
24th Oct 20227:00 amRNSInvestor Presentation
20th Oct 20227:00 amRNSNAV Update and Dividend Declaration
7th Sep 20223:11 pmRNSResult of AGM
22nd Aug 20227:00 amRNSSale of 225 Bath Street, Glasgow
12th Aug 20227:00 amRNSAcquisition of high yielding Glasgow leisure asset
28th Jul 20227:00 amRNSInvestor Presentation
27th Jul 20227:00 amRNSNAV Update and Dividend Declaration
22nd Jun 20227:00 amRNSAnnual Financial Report
17th Jun 202212:20 pmRNSDirector Declaration
10th Jun 20227:00 amRNSAcquisition of Railway Station Retail Park
20th May 20225:28 pmRNSClosed Period - Compliance with MAR
20th May 20229:33 amRNSAEWU to present at Mello Trusts & Funds conference
12th May 20227:00 amRNSAEW UK REIT plc secures new debt facility
5th May 20227:01 amEQSAEW UK REIT plc: Manager Update
27th Apr 20227:01 amEQSInvestor Presentation
25th Apr 20227:01 amEQSEastpoint Business Park, Oxford

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.